UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MSCopilot, a new multiple sclerosis self‐assessment digital solution: results of a comparative study versus standard tests

European journal of neurology, 2020-03, Vol.27 (3), p.429-436

2020

Volltextzugriff (PDF)

Contribution of imaging to the diagnosis of optic neuropathies

Revue neurologique, 2012-10, Vol.168 (10), p.702-705

Tourbah, A.

2012

Volltextzugriff (PDF)

Severe multiple sclerosis reactivation under fingolimod 3 months after natalizumab withdrawal

Multiple sclerosis, 2012-11, Vol.18 (11), p.1647-1649

2012

Volltextzugriff (PDF)

Immunosuppressive therapy is more effective than interferon in neuromyelitis optica

Multiple sclerosis, 2007-03, Vol.13 (2), p.256-259

2007

Volltextzugriff (PDF)

Secondary progressive multiple sclerosis: A national consensus paper on diagnostic criteria

Revue neurologique, 2022-12, Vol.178 (10), p.1098-1104

2022

Volltextzugriff (PDF)

Theoretical modeling of time-dependent skin temperature and heat losses during whole-body cryotherapy: a pilot study

Medical hypotheses, 2016-11, Vol.96, p.11-15

2016

Volltextzugriff (PDF)

Health related quality of life and perceived social support in French and Lebanese MS patients: A comparative study

Multiple sclerosis and related disorders, 2022-05, Vol.61, p.103758, Article 103758

2022

Volltextzugriff (PDF)

Progressive neuropsychiatric manifestations of phenylketonuria in adulthood

Revue neurologique, 2014-04, Vol.170 (4), p.280-287

2014

Volltextzugriff (PDF)

Dramatic worsening following plasma exchange in severe post-natalizumab withdrawal multiple sclerosis relapse

Multiple sclerosis, 2011-12, Vol.17 (12), p.1520-1522

2011

Volltextzugriff (PDF)

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

Lancet neurology, 2019-09, Vol.18 (9), p.845-856

2019

Volltextzugriff (PDF)

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

The New England journal of medicine, 2017-01, Vol.376 (3), p.209-220

2017

Volltextzugriff (PDF)

A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort

European journal of neurology, 2014-01, Vol.21 (1), p.40-48

2014

Volltextzugriff (PDF)

Acute disseminated encephalomyelitis in two renal transplant patients: is there a role for Epstein-Barr virus reactivation?

Multiple sclerosis, 2013-08, Vol.19 (9), p.1222-1225

2013

Volltextzugriff (PDF)

Age at onset determines the occurrence of the progressive phase of multiple sclerosis

Neurology, 2007-03, Vol.68 (10), p.779-781

2007

Volltextzugriff (PDF)

Facial Emotion Recognition and Faux Pas Interpretation in Multiple Sclerosis

Brain impairment, 2015-12, Vol.16 (3), p.158-172

2015

Volltextzugriff (PDF)

Chronic meningoencephalitis with dementia

Revue neurologique, 2014-06, Vol.170 (6-7), p.465

2014

Volltextzugriff (PDF)

Méningo-encéphalite chronique révélée par un syndrome démentiel

Revue neurologique, 2014-06, Vol.170 (6-7), p.465-467

2014

Volltextzugriff (PDF)

Eight and a half plus syndrome as a first presentation of multiple sclerosis

Revue neurologique, 2014-08, Vol.170 (8-9), p.553

2014

Volltextzugriff (PDF)

Une hyperthyroïdie énigmatique… de l’importance des interférences dans les dosages hormonaux

Annales d'endocrinologie, 2015-09, Vol.76 (4), p.428-428

2015

Volltextzugriff (PDF)

Leukoencephalopathies associated with inborn errors of metabolism in adults

Journal of inherited metabolic disease, 2008-06, Vol.31 (3), p.295-307

2008

Volltextzugriff (PDF)

MRI in diagnosis and follow-up of patients with adult metabolic disease: contribution of new techniques

Revue neurologique, 2011-03, Vol.167 (3), p.216-220

2011

Volltextzugriff (PDF)

Un syndrome « huit et demi plus » révélateur de sclérose en plaques

Revue neurologique, 2014-08, Vol.170 (8-9), p.553-554

2014

Volltextzugriff (PDF)

Optical coherence tomography in neuro-ophthalmology

Journal francais d'ophtalmologie, 2012-06, Vol.35 (6), p.454

2012

Volltextzugriff (PDF)

Leucoencéphalopathie multifocale progressive (LEMP) et syndrome de reconstitution immune (SRI) sous natalizumab (NZB) : importance de l’IRM

Revue neurologique, 2014-01, Vol.170 (1), p.48-50

2014

Volltextzugriff (PDF)

1 – 25 von 321

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(289)
Mit Volltextzugriff
(222)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

MSCopilot, a new multiple sclerosis self‐assessment digital solution: results of a comparative study versus standard tests

Contribution of imaging to the diagnosis of optic neuropathies

Severe multiple sclerosis reactivation under fingolimod 3 months after natalizumab withdrawal

Immunosuppressive therapy is more effective than interferon in neuromyelitis optica

Secondary progressive multiple sclerosis: A national consensus paper on diagnostic criteria

Theoretical modeling of time-dependent skin temperature and heat losses during whole-body cryotherapy: a pilot study

Health related quality of life and perceived social support in French and Lebanese MS patients: A comparative study

Progressive neuropsychiatric manifestations of phenylketonuria in adulthood

Dramatic worsening following plasma exchange in severe post-natalizumab withdrawal multiple sclerosis relapse

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort

Acute disseminated encephalomyelitis in two renal transplant patients: is there a role for Epstein-Barr virus reactivation?

Age at onset determines the occurrence of the progressive phase of multiple sclerosis

Facial Emotion Recognition and Faux Pas Interpretation in Multiple Sclerosis

Chronic meningoencephalitis with dementia

Méningo-encéphalite chronique révélée par un syndrome démentiel

Eight and a half plus syndrome as a first presentation of multiple sclerosis

Une hyperthyroïdie énigmatique… de l’importance des interférences dans les dosages hormonaux

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study

Leukoencephalopathies associated with inborn errors of metabolism in adults

MRI in diagnosis and follow-up of patients with adult metabolic disease: contribution of new techniques

Un syndrome « huit et demi plus » révélateur de sclérose en plaques

Optical coherence tomography in neuro-ophthalmology

Leucoencéphalopathie multifocale progressive (LEMP) et syndrome de reconstitution immune (SRI) sous natalizumab (NZB) : importance de l’IRM

Suchergebnisse filtern